Order Article Reprints

Gonçalves L, Guedes H, Fortuna AR, Lemos T, Gramaça J, Mourão N, Cunha G, Pichel R, Simões P, Luís JA, et al. Avelumab Maintenance Therapy in Advanced Urothelial Carcinoma: Implications of Timing and Treatment Sequencing. Cancers. 2025; 17(5):898. https://doi.org/10.3390/cancers17050898

Gonçalves, Lisa, Helena Guedes, Ana Raquel Fortuna, Tânia Lemos, João Gramaça, Natacha Mourão, Gonçalo Cunha, Rita Pichel, Pedro Simões, Joana Alves Luís, and et al. 2025. "Avelumab Maintenance Therapy in Advanced Urothelial Carcinoma: Implications of Timing and Treatment Sequencing" Cancers 17, no. 5: 898. https://doi.org/10.3390/cancers17050898

Gonçalves, L., Guedes, H., Fortuna, A. R., Lemos, T., Gramaça, J., Mourão, N., Cunha, G., Pichel, R., Simões, P., Luís, J. A., Freitas, R., Dunões, I., Spencer, A. S., Marinho, J., & Costa, L. (2025). Avelumab Maintenance Therapy in Advanced Urothelial Carcinoma: Implications of Timing and Treatment Sequencing. Cancers, 17(5), 898. https://doi.org/10.3390/cancers17050898